ASD holdings
Defiance Autism Impact ETF
Positions
39 stored of 39 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Definium Therapeutics Inc | CA24477V1058 | 24477V105 | 4.770% | $64K | Equity (common) | Corporate | United States | USD |
| 2 | Neuren Pharmaceuticals Ltd | NZNEUE0001S8 | Not reported | 3.235% | $44K | Equity (common) | Corporate | Australia | AUD |
| 3 | LifeStance Health Group Inc | US53228F1012 | 53228F101 | 3.043% | $41K | Equity (common) | Corporate | United States | USD |
| 4 | Otsuka Holdings Co Ltd | JP3188220002 | Not reported | 2.953% | $40K | Equity (common) | Corporate | Japan | JPY |
| 5 | Acadia Healthcare Co Inc | US00404A1097 | 00404A109 | 2.903% | $39K | Equity (common) | Corporate | United States | USD |
| 6 | ACADIA Pharmaceuticals Inc | US0042251084 | 004225108 | 2.891% | $39K | Equity (common) | Corporate | United States | USD |
| 7 | MapLight Therapeutics Inc | US56565P1030 | 56565P103 | 2.886% | $39K | Equity (common) | Corporate | United States | USD |
| 8 | AbbVie Inc | US00287Y1091 | 00287Y109 | 2.719% | $37K | Equity (common) | Corporate | United States | USD |
| 9 | BrightSpring Health Services I BrightSpring Health Services Inc | US10950A1060 | 10950A106 | 2.705% | $37K | Equity (common) | Corporate | United States | USD |
| 10 | Revvity Inc | US7140461093 | 714046109 | 2.685% | $36K | Equity (common) | Corporate | United States | USD |
| 11 | Bright Horizons Family Solutio Bright Horizons Family Solutions Inc | US1091941005 | 109194100 | 2.655% | $36K | Equity (common) | Corporate | United States | USD |
| 12 | Medicover AB | SE0009778848 | W56135101 | 2.632% | $36K | Equity (common) | Corporate | Sweden | SEK |
| 13 | Ipsen SA | FR0010259150 | Not reported | 2.600% | $35K | Equity (common) | Corporate | France | EUR |
| 14 | Sumitomo Pharma Co Ltd | JP3495000006 | Not reported | 2.598% | $35K | Equity (common) | Corporate | Japan | JPY |
| 15 | Johnson & Johnson | US4781601046 | 478160104 | 2.594% | $35K | Equity (common) | Corporate | United States | USD |
| 16 | Brainsway Ltd | US10501L1061 | 10501L106 | 2.583% | $35K | Equity (common) | Corporate | Israel | USD |
| 17 | Pearson PLC | GB0006776081 | Not reported | 2.564% | $35K | Equity (common) | Corporate | United Kingdom | GBP |
| 18 | Anavex Life Sciences Corp | US0327973006 | 032797300 | 2.534% | $34K | Equity (common) | Corporate | United States | USD |
| 19 | Novartis AG | CH0012005267 | Not reported | 2.532% | $34K | Equity (common) | Corporate | Switzerland | CHF |
| 20 | Life Healthcare Group Holdings Life Healthcare Group Holdings Ltd | ZAE000145892 | Not reported | 2.519% | $34K | Equity (common) | Corporate | South Africa | ZAR |
| 21 | BioMarin Pharmaceutical Inc | US09061G1013 | 09061G101 | 2.516% | $34K | Equity (common) | Corporate | United States | USD |
| 22 | KPJ Healthcare Bhd | MYL5878OO003 | Not reported | 2.513% | $34K | Equity (common) | Corporate | Malaysia | MYR |
| 23 | Repligen Corp | US7599161095 | 759916109 | 2.505% | $34K | Equity (common) | Corporate | United States | USD |
| 24 | Roche Holding AG | CH1499059983 | Not reported | 2.504% | $34K | Equity (common) | Corporate | Switzerland | CHF |
| 25 | Supernus Pharmaceuticals Inc | US8684591089 | 868459108 | 2.499% | $34K | Equity (common) | Corporate | United States | USD |
| 26 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | Not reported | 2.497% | $34K | Equity (common) | Corporate | Ireland | USD |
| 27 | Eli Lilly & Co | US5324571083 | 532457108 | 2.486% | $34K | Equity (common) | Corporate | United States | USD |
| 28 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 2.474% | $33K | Equity (common) | Corporate | United States | USD |
| 29 | GSK PLC | GB00BN7SWP63 | Not reported | 2.460% | $33K | Equity (common) | Corporate | United Kingdom | GBP |
| 30 | Vanda Pharmaceuticals Inc | US9216591084 | 921659108 | 2.453% | $33K | Equity (common) | Corporate | United States | USD |
| 31 | Graham Holdings Co | US3846371041 | 384637104 | 2.366% | $32K | Equity (common) | Corporate | United States | USD |
| 32 | Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd | IL0006290147 | Not reported | 2.351% | $32K | Equity (common) | Corporate | Israel | ILS |
| 33 | Takeda Pharmaceutical Co Ltd | JP3463000004 | Not reported | 2.348% | $32K | Equity (common) | Corporate | Japan | JPY |
| 34 | Grand Canyon Education Inc | US38526M1062 | 38526M106 | 2.309% | $31K | Equity (common) | Corporate | United States | USD |
| 35 | H Lundbeck A/S | DK0061804770 | Not reported | 2.293% | $31K | Equity (common) | Corporate | Denmark | DKK |
| 36 | Shionogi & Co Ltd | JP3347200002 | Not reported | 2.286% | $31K | Equity (common) | Corporate | Japan | JPY |
| 37 | Pfizer Inc | US7170811035 | 717081103 | 2.249% | $30K | Equity (common) | Corporate | United States | USD |
| 38 | Stride Inc | US86333M1080 | 86333M108 | 2.119% | $29K | Equity (common) | Corporate | United States | USD |
| 39 | First American Government Obli First American Government Obligations Fund | US31846V3362 | 31846V336 | 0.214% | $3K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |